About Sterling Accuris Diagnostics
Sterling Accuris Diagnostics is a company based in Ahmedabad (India) founded in 2015 by Rajiv Sharma. Sterling Accuris Diagnostics has raised $41.69 million across 4 funding rounds from investors including Morgan Stanley, Nhpea Nanda Devi Holding and Udhay Vi Realty. The company has 1,122 employees as of April 08, 2024. Sterling Accuris Diagnostics has completed 3 acquisitions, including Gujarat Pathology Laboratory, VIP Pathology Lab and Vaibhav Analytical. Sterling Accuris Diagnostics operates in a competitive market with competitors including Dr Lal PathLabs, Redcliffe Labs, Orange health, Metropolis India and Agilus Diagnostics, among others.
- Headquarter Ahmedabad, India
- Employees 1122 as on 08 Apr, 2024
- Founders Rajiv Sharma
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sterling Accuris Wellness Private Limited
- Date of Incorporation 26 Sep, 2014
- Jurisdiction Ahmedabad, Gujarat, India
-
Annual Revenue
$21.42 M (USD)28.89as on Mar 31, 2022
-
Net Profit
$473.99 K (USD)-14.47as on Mar 31, 2022
-
EBITDA
$2.21 M (USD)26.56as on Mar 31, 2022
-
Total Equity Funding
$41.69 M (USD)
in 4 rounds
-
Latest Funding Round
$34 M (USD), Series C
Sep 24, 2021
-
Investors
Morgan Stanley
& 6 more
-
Employee Count
1122
as on Apr 08, 2024
-
Investments & Acquisitions
Gujarat Pathology Laboratory
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sterling Accuris Diagnostics
Sterling Accuris Diagnostics has successfully raised a total of $41.69M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $34 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sterling Accuris Diagnostics
Sterling Accuris Diagnostics has secured backing from 7 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Morgan Stanley, Nhpea Nanda Devi Holding and Udhay Vi Realty.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on healthcare and multiple sectors
|
Locked | Locked | Locked | |
|
Multiple sectors are invested in by this private equity firm.
|
Locked | Locked | Locked | |
|
Wealth management, investment advisory, and financial services are provided.
|
Locked | Locked | Locked |
Investor details for Sterling Accuris Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sterling Accuris Diagnostics
Sterling Accuris Diagnostics has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Gujarat Pathology Laboratory, VIP Pathology Lab and Vaibhav Analytical.
Investment portfolio details for Sterling Accuris Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmaceutical testing and research are conducted by the laboratory.
|
Locked | Locked | 1999 | Locked | |
|
A chain of pathology laboratories and diagnostic centers is operated.
|
Locked | Locked | 1998 | Locked | |
|
A chain of pathology labs for diagnostic testing is operated.
|
Locked | Locked | 1997 | Locked |
Complete acquisition details for Sterling Accuris Diagnostics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Sterling Accuris Diagnostics
Detailed financials for Sterling Accuris Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sterling Accuris Diagnostics Comparisons
Peer comparison for Sterling Accuris Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sterling Accuris Diagnostics
Sterling Accuris Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dr Lal PathLabs, Redcliffe Labs, Orange health, Metropolis India and Agilus Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Chain of pathology and radiology labs
|
|
| Locked | Locked | Locked |
Home-based diagnostic tests are booked via an online platform.
|
|
| Locked | Locked | Locked |
At-home diagnostic tests are booked and collected by phlebotomists.
|
|
| Locked | Locked | Locked |
Diagnostic centers are operated as a nationwide chain.
|
|
| Locked | Locked | Locked |
Leading diagnostic chain providing quality blood test and full body checkup services
|
Detailed competitors of Sterling Accuris Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sterling Accuris Diagnostics
Complete news archive for Sterling Accuris Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sterling Accuris Diagnostics
Sterling Accuris Diagnostics was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Sterling Accuris Diagnostics is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Rajiv Sharma is the current CEO of Sterling Accuris Diagnostics. They have also founded this company.
Sterling Accuris Diagnostics is a funded company, having raised a total of $41.69M across 4 funding rounds to date.
As of Apr 08, 2024, the latest employee count at Sterling Accuris Diagnostics is 1,122.
Annual revenue of Sterling Accuris Diagnostics is $21.42M as on Mar 31, 2022.
Sterling Accuris Diagnostics was founded in 2015 and is headquartered in Ahmedabad, India. Operations focus on the healthcare sector, specifically pathology and diagnostic testing. A network of labs is maintained to deliver clinical testing services, including blood analysis and other diagnostic procedures, primarily serving patients across India. The company is led by founder and CEO Rajiv Sharma.
Sterling Accuris Diagnostics's top competitors include Dr Lal PathLabs, Redcliffe Labs and Metropolis India.
Sterling Accuris Diagnostics has made 3 acquisitions, including Gujarat Pathology Laboratory, VIP Pathology Lab, and Vaibhav Analytical.
Sterling Accuris Diagnostics has 7 investors. Key investors include Morgan Stanley, Nhpea Nanda Devi Holding, Udhay Vi Realty, Girishbhai Naranbhai Patel, and Rajiv Sharma.
The valuation of Sterling Accuris Diagnostics is $95.03M as of Sep 2021.